Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George I Papakostas

Showing results (1-10 of 228) with videos related to

Pageof 23
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 18, 2006
Dopaminergic-based pharmacotherapies for depressionGeorge I Papakostas
The Journal of Clinical Psychiatry|November 20, 2009
Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorderGeorge I Papakostas
The Journal of Clinical Psychiatry|February 2, 2016
Identifying patients with depression who require a change in treatment and implementing that changeGeorge I Papakostas
The Journal of Clinical Psychiatry|December 19, 2013
Cognitive symptoms in patients with major depressive disorder and their implications for clinical practiceGeorge I Papakostas
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|December 25, 2010
Switching, combination, and augmentation strategies for major depressive disorderGeorge I Papakostas
The American Journal of Psychiatry|December 10, 2015
Reply to Fleisch et al. LetterGeorge I Papakostas
The Journal of Clinical Psychiatry|October 16, 2007
Limitations of contemporary antidepressants: tolerabilityGeorge I Papakostas
The International Journal of Neuropsychopharmacology|August 5, 2011
Surrogate markers of treatment outcome in major depressive disorderGeorge I Papakostas
The Journal of Clinical Psychiatry|May 1, 2009
Diagnostic assessment of major depressive disorderGeorge I Papakostas
The Journal of Clinical Psychiatry|April 8, 2010
The efficacy, tolerability, and safety of contemporary antidepressantsGeorge I Papakostas
Pageof 23

Showing results (1-10 of 228) with videos related to

Sort By:
Pageof 23
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 18, 2006
Dopaminergic-based pharmacotherapies for depressionGeorge I Papakostas
The Journal of Clinical Psychiatry|November 20, 2009
Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorderGeorge I Papakostas
The Journal of Clinical Psychiatry|February 2, 2016
Identifying patients with depression who require a change in treatment and implementing that changeGeorge I Papakostas
The Journal of Clinical Psychiatry|December 19, 2013
Cognitive symptoms in patients with major depressive disorder and their implications for clinical practiceGeorge I Papakostas
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|December 25, 2010
Switching, combination, and augmentation strategies for major depressive disorderGeorge I Papakostas
The American Journal of Psychiatry|December 10, 2015
Reply to Fleisch et al. LetterGeorge I Papakostas
The Journal of Clinical Psychiatry|October 16, 2007
Limitations of contemporary antidepressants: tolerabilityGeorge I Papakostas
The International Journal of Neuropsychopharmacology|August 5, 2011
Surrogate markers of treatment outcome in major depressive disorderGeorge I Papakostas
The Journal of Clinical Psychiatry|May 1, 2009
Diagnostic assessment of major depressive disorderGeorge I Papakostas
The Journal of Clinical Psychiatry|April 8, 2010
The efficacy, tolerability, and safety of contemporary antidepressantsGeorge I Papakostas
Pageof 23